Idiopathic pulmonary fibrosis: present understandings and future directions

Evening Symposium
Chairs: R. M. du Bois (London, United Kingdom)

Introduction R. M. du Bois (London, United Kingdom)
Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) D. Valeyre (Paris, France)
Challenges in IPF trials: the point on endpoints C. Albera (Turin, Italy)
Emerging Potential Treatments: new hope for patients? U. Costabel (Essen, Germany)
Follow-up and nonpharmacological management of the IPF patient J. J. G. Egan (Dublin, Ireland)
Summary R. M. du Bois (London, United Kingdom)